Related Experiment Video
Updated: Jun 21, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Age and body weight adjusted warfarin initiation program for ischaemic stroke patients
1Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
European Journal of Neurology
|July 21, 2009
Summary
This study developed an individualized warfarin initiation program for stroke patients, identifying age and weight as key factors. The program aims to optimize anticoagulation therapy and reduce bleeding risks.
Area of Science:
- Neurology
- Pharmacology
- Clinical Medicine
Background:
- Anticoagulation is effective for stroke but carries bleeding risks, limiting its use in acute ischemic stroke.
- Developing safe and effective anticoagulation strategies for stroke patients remains a critical clinical challenge.
Purpose of the Study:
- To develop an individualized warfarin initiation program for patients with acute or subacute ischemic stroke.
- To optimize warfarin dosing to achieve target International Normalized Ratio (INR) safely and efficiently.
Main Methods:
- Retrospective analysis of 321 stroke patients on stable warfarin doses.
- Identified patient factors influencing warfarin maintenance dose, including age and body weight.
- Developed a decision tree for individualized warfarin initiation doses based on patient characteristics.
Main Results:
- Median warfarin maintenance dose was 4 mg/day; age and body weight significantly predicted dose requirements.
- Patients were categorized into high (HG), standard, and low (LG) dose groups.
- Recommended initial warfarin doses: 7 mg (standard), 10 mg (HG), and 5 mg (LG).
Conclusions:
- The developed individualized program is expected to reduce time to target INR and minimize excessive anticoagulation.
- Further prospective studies are necessary to validate the efficacy and safety of this program in acute stroke patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...